Your browser doesn't support javascript.
loading
Systematic screening of synthetic organochalcogen compounds with anticancer activity using human lung adenocarcinoma spheroids.
Batista, Jéssica Eduarda Dos Santos; Rodrigues, Mariele Borkowski; Bristot, Ivi Juliana; Silva, Valquíria; Bernardy, Silvia; Rodrigues, Oscar Endrigo Dorneles; Dornelles, Luciano; Carvalho, Fabiano Barbosa; de Sousa, Francisca Joseli Freitas; Fernandes, Marilda da Cruz; Zanatta, Geancarlo; Soares, Félix Alexandre Antunes; Klamt, Fábio.
Affiliation
  • Batista JEDS; Department of Biochemistry and Molecular Biology, Federal University of Santa Maria (UFSM), Santa Maria, RS, 97105-900, Brazil; Laboratory of Cellular Biochemistry, Department of Biochemistry, Institute of Basic Health Sciences (ICBS), Federal University of Rio Grande Do Sul (UFRGS), Porto Alegre, R
  • Rodrigues MB; Department of Chemistry, Federal University of Santa Maria (UFSM), Santa Maria, RS, 97105-900, Brazil.
  • Bristot IJ; Laboratory of Cellular Biochemistry, Department of Biochemistry, Institute of Basic Health Sciences (ICBS), Federal University of Rio Grande Do Sul (UFRGS), Porto Alegre, RS, 90035-003, Brazil; National Institutes of Science and Technology-Translational Medicine (INCT-TM), Brazil.
  • Silva V; Laboratory of Cellular Biochemistry, Department of Biochemistry, Institute of Basic Health Sciences (ICBS), Federal University of Rio Grande Do Sul (UFRGS), Porto Alegre, RS, 90035-003, Brazil; National Institutes of Science and Technology-Translational Medicine (INCT-TM), Brazil.
  • Bernardy S; Department of Chemistry, Federal University of Santa Maria (UFSM), Santa Maria, RS, 97105-900, Brazil.
  • Rodrigues OED; Department of Chemistry, Federal University of Santa Maria (UFSM), Santa Maria, RS, 97105-900, Brazil.
  • Dornelles L; Department of Chemistry, Federal University of Santa Maria (UFSM), Santa Maria, RS, 97105-900, Brazil.
  • Carvalho FB; Pathology Laboratory, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS, 90050-170, Brazil.
  • de Sousa FJF; Postgraduate Program in Biochemistry at Federal University of Ceará (UFC), Fortaleza, CE, 60440-900, Brazil.
  • Fernandes MDC; Pathology Laboratory, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS, 90050-170, Brazil.
  • Zanatta G; Department of Biophysics, UFRGS, Porto Alegre, RS, 91501-970, Brazil.
  • Soares FAA; Department of Biochemistry and Molecular Biology, Federal University of Santa Maria (UFSM), Santa Maria, RS, 97105-900, Brazil.
  • Klamt F; Laboratory of Cellular Biochemistry, Department of Biochemistry, Institute of Basic Health Sciences (ICBS), Federal University of Rio Grande Do Sul (UFRGS), Porto Alegre, RS, 90035-003, Brazil; National Institutes of Science and Technology-Translational Medicine (INCT-TM), Brazil. Electronic address
Chem Biol Interact ; 396: 111047, 2024 Jun 01.
Article in En | MEDLINE | ID: mdl-38735454
ABSTRACT
Lung adenocarcinoma stands as a leading global cause of cancer-related fatalities, with current therapeutic approaches remaining unsatisfactory. Given the association between elevated oxidative markers and the aggressive nature of cancer cells (including multidrug resistance and metastatic potential) that can predict poor outcome of lung adenocarcinoma patients, any compounds that interfere with their aberrant redox biology should be rationally explored as innovative intervention strategies. This study was designed to screen potential anticancer activities within nine newly synthesized organochalcogen - compounds characterized by the presence of oxygen, sulfur, or selenium elements in their structure and exhibiting antioxidant activity - and systematically evaluated their performance against cisplatin, the cornerstone therapeutic agent for lung adenocarcinoma. Our methodology involved the establishment of optimal conditions for generating single tumor spheroids using A549 human lung adenocarcinoma cell line. The initiation interval for spheroid formation was determined to be four days in vitro (DIV), and these single spheroids demonstrated sustained growth over a period of 20 DIV. Toxic dose-response curves were subsequently performed for each compound after 24 and 48 h of incubation at the 12th DIV. Our findings reveal that at least two of the synthetic organochalcogen compounds exhibited noteworthy anticancer activity, surpassing cisplatin in key parameters such as lower LD (Lethal Dose) 50, larger drug activity area, and maximum amplitude of effect, and are promising drugs for futures studies in the treatment of lung adenocarcinomas. Physicochemical descriptors and prediction ADME (absorption, distribution, metabolism, and excretion) parameters of selected compounds were obtained using SwissADME computational tool; Molinspiration server was used to calculate a biological activity score, and possible molecule targets were evaluated by prediction with the SwissTargetPrediction server. This research not only sheds light on novel avenues for therapeutic exploration but also underscores the potential of synthetic organochalcogen compounds as agents with superior efficacy compared to established treatments.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cisplatin / Chalcogens / Spheroids, Cellular / Adenocarcinoma of Lung / Lung Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Chem Biol Interact / Chem. biol. interact / Chemico-biological interactions Year: 2024 Document type: Article Country of publication: Irlanda

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cisplatin / Chalcogens / Spheroids, Cellular / Adenocarcinoma of Lung / Lung Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Chem Biol Interact / Chem. biol. interact / Chemico-biological interactions Year: 2024 Document type: Article Country of publication: Irlanda